{"url_path":"/sec/acet/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1720580/0001720580-26-000037-index.html","accession_number":"0001720580-26-000037","cik":"0001720580","ticker":"ACET","issuer_name":"Adicet Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1720580/0001720580-26-000037-index.html","primary_entity_key":"0001720580","primary_entity_name":"Adicet Bio, Inc."},"word_count":57,"has_tables":true,"body_markdown":"Item 5. Other Information.\n\n(c) None of our directors or “officers,” as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, adopted or terminated a Rule 10b5-1 trading plan or arrangement or a non-Rule 10b5-1 trading plan or arrangement, as defined in Item 408(c) of Regulation S-K, during the fiscal quarter covered by this report."}